Four Cycles of Etoposide plus Cisplatin for Patients with Good‐Risk Advanced Germ Cell Tumors

BACKGROUND: The National Comprehensive Cancer Network recommends either three cycles of bleomycin, etoposide, and cisplatin or four cycles of etoposide and cisplatin (EPx4) as initial chemotherapy for the treatment of good‐risk germ cell tumors (GCTs). To assess the response, toxicity, and survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Funt, Samuel A., McHugh, Deaglan J., Tsai, Stephanie, Knezevic, Andrea, O'Donnell, Devon, Patil, Sujata, Silber, Deborah, Bromberg, Maria, Carousso, Maryann, Reuter, Victor E., Carver, Brett S., Sheinfeld, Joel, Motzer, Robert J., Bajorin, Dean F., Bosl, George J., Feldman, Darren R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Genitourinary Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176973/
https://www.ncbi.nlm.nih.gov/pubmed/33586274
http://dx.doi.org/10.1002/onco.13719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176973/
https://www.ncbi.nlm.nih.gov/pubmed/33586274
http://dx.doi.org/10.1002/onco.13719

Ejemplares similares